science

Infigratinib

Infigratinib is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Infigratinib rather than just read about it. In short: Infigratinib is an kinase inhibitor in development for the treatment of achondroplasia and hypochondroplasia. Infigratinib is an oral small molecule that targets the fibroblast growth factor receptors FGFR1, FGFR2, and FGFR3.

Key takeaways

Infigratinib belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Infigratinib to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Infigratinib from memory before moving on to harder problems.

Reference excerpt

Infigratinib is an kinase inhibitor in development for the treatment of achondroplasia and hypochondroplasia. Infigratinib is an oral small molecule that targets the fibroblast growth factor receptors FGFR1, FGFR2, and FGFR3. Unlike other therapeutics in development or approved for achondroplasia, it is a daily oral capsule.

History Infigratinib is currently in clinical trials for the treatment of children with achondroplasia and hypochondroplasia, conditions caused by variants in the FGFR3 gene. Recent Phase 3 clinical trial results for infigratinib demonstrated an improvement in annualized growth velocity of +2.1 cm/yr compared to placebo, the largest reported in any Phase 3 trial for achondroplasia. Infigratinib also demonstrated a statistically significant change in upper-to-lower body proportionality in children 3-8 years of age. There were no treatment-related serious adverse events, and the drug was well-tolerated. Earlier Phase 2 results of infigratinib for the treatment of achondroplasia were published in the New England Journal of Medicine.

Society and culture

Legal status Infigratinib received Breakthrough Therapy Designation from the FDA, the first therapeutic option in development for achondroplasia to receive this designation. Infigratinib was designated an orphan drug by the FDA and the European Medicines Agency in 2021. It was previously approved for medical use for bile duct cancer under the FDA's accelerated approval program in May 2021 at a significantly higher dose than that used for achondroplasia or hypochondroplasia.

References

External links Clinical trial number NCT02150967 for "A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma" at ClinicalTrials.gov

Worked examples

Example 1 — a first encounter with Infigratinib

Start with the simplest possible case. Write down what Infigratinib claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Infigratinib before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Infigratinib ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Infigratinib

In research: Infigratinib appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Infigratinib in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Infigratinib is common in secondary-school and first-year university syllabi. It links to neighbouring topics Orphan drugs, Receptor tyrosine kinase inhibitors, so understanding it makes those chapters shorter.
In everyday life: Look for Infigratinib outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Infigratinib in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Infigratinib means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Infigratinib out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Infigratinib in simple terms?

Why does Infigratinib matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Infigratinib?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Infigratinib.